-
Company Insights
Innovation and Patenting activity of Silk Road Medical Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Silk Road Medical Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
NewHyaluronic Acid Fillers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Hyaluronic Acid Fillers Pipeline Market Report Overview Hyaluronic Acid (HA) is a glycosaminoglycan disaccharide, which exists naturally in the body. Approximately 50% of the total HA is found in the skin. Injections of HA are used for reducing wrinkles in the face and for soft tissue augmentation. The hyaluronic acid fillers pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the...
-
Sector Analysis
Carotid and Renal Artery Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Carotid and Renal Artery Stents Market Report Overview The carotid and renal artery stents market size was $1.09 billion in 2023. The market is expected to grow at a CAGR of more than 3% during 2023-2033. Carotid artery stents are expandable tubes that are implanted in narrowed carotid arteries to increase the flow of blood. Renal artery stents are expandable tubes that are implanted to increase blood flow in the narrowed renal artery. Carotid and Renal Artery Stents Market Outlook,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VX-103 in Influenza A Virus, H1N1 Subtype Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VX-103 in Influenza A Virus, H1N1 Subtype Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VX-103 in Influenza A Virus, H1N1 Subtype Infections...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VX-103 in Seasonal Influenza
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VX-103 in Seasonal Influenza report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VX-103 in Seasonal Influenza Drug Details: VX-103 is under development for the...
-
Product Insights
Keratoconjunctivitis Sicca (Dry Eye) – Drugs In Development, 2023
Global Markets Direct’s, ‘Keratoconjunctivitis Sicca (Dry Eye) - Drugs In Development, 2023’, provides an overview of the Keratoconjunctivitis Sicca (Dry Eye) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Keratoconjunctivitis Sicca (Dry Eye), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Keratoconjunctivitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Keratoconjunctivitis - Drugs In Development, 2023’, provides an overview of the Keratoconjunctivitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Keratoconjunctivitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Hassyan Thermal Power Plant
Hassyan Thermal Power Plant is a thermal project located in Dubai, United Arab Emirates. The project is owned by Acwa Power Co; Dubai Electricity and Water Authority; Harbin Electric International Co Ltd; Silk Road Fund Co Ltd and is developed by Hassyan Energy Phase 1 PSC. The project is currently partially active. Empower your strategies with our Hassyan Thermal Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Influenza (Pentavalent) Vaccine in Seasonal Influenza
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Influenza (Pentavalent) Vaccine in Seasonal Influenza report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Influenza (Pentavalent) Vaccine in Seasonal Influenza Drug Details:Vaccine is under development...
-
Product Insights
Dairut Combined Cycle Power Plant
Dairut Combined Cycle Power Plant is a thermal project located in Luxor, Egypt. The project is owned by Acwa Power Co; GE Power; Hassan Allam Holding SAE; Silk Road Fund Co Ltd; The Saudi Public Investment Fund and is developed by Acwa Power Co; Hassan Allam Holding SAE. The project is at the permitting stage. Empower your strategies with our Dairut Combined Cycle Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will...